Reputation, public information, and physician adoption of an innovation.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 103, doi. 10.1007/s10198-002-0099-4
- By:
- Publication type:
- Article
Works matching IS 16187598 AND DT 2002 AND VI 3 AND IP 2
Results: 16
1
2
Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 111, doi. 10.1007/s10198-002-0097-6
- By:
- Publication type:
- Article
3
A final comment.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 142, doi. 10.1007/s10198-002-0124-7
- By:
- Publication type:
- Article
4
Drug licensing requirements are changing!
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 141, doi. 10.1007/s10198-002-0123-8
- By:
- Publication type:
- Article
5
Time for a change in drug pricing : Going downstream.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 140, doi. 10.1007/s10198-002-0122-9
- By:
- Publication type:
- Article
6
Commentary.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 139, doi. 10.1007/s10198-002-0121-x
- By:
- Publication type:
- Article
7
Commentary.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 138, doi. 10.1007/s10198-002-0120-y
- By:
- Publication type:
- Article
8
Time for a change in drug licensing requirements?
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 137, doi. 10.1007/s10198-002-0119-4
- By:
- Publication type:
- Article
9
Genetic testing and the health care system.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 73, doi. 10.1007/s10198-002-0106-9
- By:
- Publication type:
- Article
10
Association of time preference for health with age and disease severity.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 120, doi. 10.1007/s10198-002-0102-0
- By:
- Publication type:
- Article
11
Erratum to: Does health technology assessment benefit health services and politics?: The experiences of an established HTA institution: the Danish Centre for Evaluation and HTA.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 124, doi. 10.1007/s10198-002-0108-7
- By:
- Publication type:
- Article
12
The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 94, doi. 10.1007/s10198-002-0104-y
- By:
- Publication type:
- Article
13
Developing a scoring system to quality assess economic evaluations.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 131, doi. 10.1007/s10198-002-0100-2
- By:
- Publication type:
- Article
14
Risk-adjusted capitation funding models for chronic disease in Australia: alternatives to casemix funding.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 83, doi. 10.1007/s10198-002-0096-7
- By:
- Publication type:
- Article
15
Is EQ-5D a valid measure of HRQoL in patients with movement disorders? : A comparison with SF-36 and FIM questionnaires.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 125, doi. 10.1007/s10198-002-0105-x
- By:
- Publication type:
- Article
16
Burden of illness imposed by severe sepsis in Germany.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 77, doi. 10.1007/s10198-002-0095-8
- By:
- Publication type:
- Article